期刊文献+

血清生长激素释放肽水平与早产儿喂养不耐受相关性研究 被引量:6

Study on the relationship between serum growth hormone releasing peptide and feeding intolerance in premature infants
下载PDF
导出
摘要 目的测定早产儿生后24 h内血清生长激素释放肽(Ghrelin)水平,探讨其与早产儿喂养不耐受的相关性。方法选取2012年5月至2012年10月生后24 h内入住安徽医科大学第一附属医院新生儿科无伴发疾病的早产儿52例(年龄<24 h)作为研究对象,采用ELISA法测定生后24 h内的血清Ghrelin水平,同时记录其喂养情况,根据是否发生喂养不耐受分为喂养不耐受组(24例)与无喂养不耐受组(28例)两组,比较两组血清Ghrelin水平。结果喂养不耐受组生后24h内血清Ghrelin水平明显低于无喂养不耐受组,差异有统计学意义[(604.79±28.07)pg/ml vs(650.75±34.34)pg/ml,P<0.05]。结论血清Ghrelin水平与早产儿喂养不耐受发生有关,早期检测血清Ghrelin水平对预测早产儿喂养不耐受有一定价值;外源性Ghrelin可能具有改善早产儿肠内喂养耐受性的作用。 Objective To study the relationship between serum growth hormone releasing peptide and feeding intolerance in prema- ture infant. Methods 52 preterm infants who were admitted to our hospital from 2012.5 to 2012.10 were divided into two groups, feeding intolerance group (24 premature infants) and non -feeding intolerance group (28 premature infants). Serum growth hormone releasing pep- tide(ghrelin) concentrations were measured by ELISA in 24 hours after birth in the two groups. Results The level of serum ghrelin in 24h after birth in feeding intolerance group was significantly lower than that in non -feeding intolerance group( 604.79±28.07 pg·ml^-1 vs 650. 75±34.34 pg·ml^-1 ) ( p 〈 0.05 ) . Conclusion The level of serum Ghrelin is related to feeding intolerance in premature infant. To detect serum Ghrelin early might be valuable to predict feeding intolerance in premature infant. Ghrelin might play a role in improve feeding intoler- ance in premature infant.
出处 《安徽医学》 2013年第7期877-879,共3页 Anhui Medical Journal
关键词 婴儿 早产 生长激素释放肽 喂养不耐受 Infant Premature Ghrelin Feeding intolerance
  • 相关文献

参考文献10

二级参考文献58

共引文献258

同被引文献53

  • 1Van der Ploeg L, Laken H, Sharma S, et al. Preclinical gastrointestinal pmkinetic efficacy and endocrine effects of the ghrelin mimetic RM-131. Life Sci, 2014, 109:20-29.
  • 2Falk6n Y,HeUstrfm PM, Sanger G J, et al. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterol Motil, 2010, 22 :e192-200.
  • 3Ashby DR, Ford HE, Wynne K J, et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int, 2009, 76:199-206.
  • 4Monteleone P, Serritella C, Martiadis V, et al. Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biol Psychiatry, 2008, 64 : 1005-1008.
  • 5Cram A J, Corbin WR, Brownell KD, et al. Mind over milkshakes : mindsets, not just nutrients, determine ghrelin response. Health Psyehol, 2011, 30:424-429.
  • 6Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med, 2008, 149: 601-611.
  • 7Harada Y, Ro S, Ochiai M, et al. Ghrelin enhancer, rikkunshito, improves postprandial gastric motor dysfunction in an experimental stress madel. Neurogastroenterol Motil, 2015, 27 : 1089-1097.
  • 8Depoortere I,De Winter B, Thijs T, et al. Comparison of the gastroprokinetie effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol, 2005, 515:160-168.
  • 9Sakata I,Nakano Y, Osborne-Lawrence S, et al. Characterization of a novel ghrelin cell reporter mouse. Regul Pept, 2009, 155 : 91-98.
  • 10MUller TD, Perez-Tilve D, Tong J, et al. Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia. J Cachexia Sarcopenia Muscle, 2010, 1:159-167.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部